POAI News and Press, Predictive Oncology Inc. From 05/10/24

Predictive Oncology (NASDAQ: POAI) , a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities to accelerate oncology drug discovery and enable drug development, today announced that it will release its financial results for the first quarter en...

PITTSBURGH, May 10, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence and machine learning capabilities, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) lab...

2024-05-08 10:36:03 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Everyone’s current favorite antagonist, Federal Reserve Chair Jerome Powell, might be turning the tide with his latest comment on the economy. In a recent address, He stated, “I d...

2024-05-08 06:45:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Artificial intelligence has fueled the stock market over the last 12 to 15 months. Many have suggested that its emergence alone is the reason the economy did not collapse in 2023 and remains st...

2024-05-06 14:47:29 ET More on Predictive Oncology Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call Transcript Predictive Oncology stock rallies 30% post-market on vaccine collaboration Financial information for Predictive Oncology Read the full articl...

2024-05-06 08:26:44 ET More on pre-market losers & stocks. GameStop: Approaching An Optimistic Fair Value But Not There Yet GameStop: Operations Are Stabilizing, But Expect More Pain To Come Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call Transcript ...

2024-05-01 10:41:49 ET DENVER, Colo., May 01, 2024 ( 247marketnews.com )- Brera Holdings (NASDAQ: BREA ), Palisade Bio, Inc. (Nasdaq: PALI ), Getaround (NYSE: GETR ), CytomX Therapeutics, Inc. (Nasdaq: CTMX ), and Predictive Oncology Inc...

Predictive Oncology (NASDAQ: POAI) , a leader in artificial-intelligence (“AI”)-driven drug discovery and biologics, is partnering with FluGen to bring a first-of-its-kind intranasal flu vaccine to market. According to the announcement, the partnership is part of a $6.2 million phas...

2024-04-30 16:45:52 ET More on Predictive Oncology Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call Transcript Financial information for Predictive Oncology Read the full article on Seeking Alpha For further details see: Predictive Oncology stock ral...

PITTSBURGH, April 30, 2024 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announces a collaboration with FluGen to bring a first-of-its-kind intranasal flu vaccine to market, as part of a $6.2 million Phase 2B grant awarded by...